| Interleukin-25 as a Potential Biomarker in Lung Metastasis of Hepatocellular Carcinoma with HBV History in Chinese Patients: A Single Center, Case-control Study. | Interleukin-25 as a Potential Biomarker in Lung Metastasis of Hepatocellular Carcinoma with HBV History in Chinese Patients: A Single Center, Case-control Study.
Liao Y, Xu Y, Mo Z, Zhu T, Dong H, Zhou W, Xia Q., Free PMC Article | 09/12/2024 |
| The Alarmin Triad-IL-25, IL-33, and TSLP-Serum Levels and Their Clinical Implications in Chronic Spontaneous Urticaria. | The Alarmin Triad-IL-25, IL-33, and TSLP-Serum Levels and Their Clinical Implications in Chronic Spontaneous Urticaria.
Dobrican-Băruța CT, Deleanu DM, Muntean IA, Nedelea I, Bălan RG, Filip GA, Procopciuc LM., Free PMC Article | 03/12/2024 |
| Proteomic Analysis by 4D Label-free MS-PRM Provides Insight into the Role and Regulatory Mechanisms of IL-25 in NK Cells. | Proteomic Analysis by 4D Label-free MS-PRM Provides Insight into the Role and Regulatory Mechanisms of IL-25 in NK Cells.
Feng J, Huang L, Yang S, Pan J, Zhu X, Tang D. | 12/22/2023 |
| Evaluation of IL-6, IL-25 & IL-35 in the COVID 19 Patients and their Correlation to Demography Data in the Symptomatic Patients. | Evaluation of IL-6, IL-25 & IL-35 in the COVID 19 Patients and their Correlation to Demography Data in the Symptomatic Patients.
Mohammed H Al-Mquter LF, Abdul Azeez Atiayh S., Free PMC Article | 12/4/2023 |
| The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. | The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
Bahhar I, Eş Z, Köse O, Turna A, Günlüoğlu MZ, Çakır A, Duralı D, Magnusson FC., Free PMC Article | 10/4/2023 |
| IL-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia. | IL-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia.
Pashei M, Ghahremanfard F, Manouchehri Doulabi E, Hemmati M, Pak F, Kokhaei P. | 08/3/2023 |
| The potential role of interleukin (IL)-25/IL-33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis. | The potential role of interleukin (IL)-25/IL-33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis.
Xu X, Dai H, Zhang J., Free PMC Article | 11/12/2022 |
| IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis. | IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Russo B, Borowczyk J, Cacialli P, Moguelet P, Truchetet ME, Modarressi A, Brembilla NC, Bertrand J, Boehncke WH, Chizzolini C. | 11/5/2022 |
| Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis. | Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis.
Jou E, Rodriguez-Rodriguez N, McKenzie ANJ., Free PMC Article | 10/29/2022 |
| The potential roles of interleukin-25 in infectious diseases. | The potential roles of interleukin-25 in infectious diseases.
Wu J, Zhang F, Tao H, Nawaz W, Chen D, Wu Z., Free PMC Article | 10/8/2022 |
| IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People. | IL-17A, IL-17E and IL-17F as Potential Biomarkers for the Intensity of Low-Grade Inflammation and the Risk of Cardiovascular Diseases in Obese People.
Polak-Szczybyło E, Tabarkiewicz J., Free PMC Article | 03/26/2022 |
| IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy. | IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy.
Tsai ML, Tsai YG, Lin YC, Hsu YL, Chen YT, Tsai MK, Liao WT, Lin YC, Hung CH., Free PMC Article | 02/5/2022 |
| Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives. | Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives.
Borgia F, Custurone P, Peterle L, Pioggia G, Gangemi S., Free PMC Article | 01/15/2022 |
| Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype. | Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
Moermans C, Damas K, Guiot J, Njock MS, Corhay JL, Henket M, Schleich F, Louis R. | 01/15/2022 |
| IL-25 promotes trophoblast proliferation and invasion via binding with IL-17RB and associated with PE. | IL-25 promotes trophoblast proliferation and invasion via binding with IL-17RB and associated with PE.
Liu S, Sun Y, Tang Y, Hu R, Zhou Q, Li X. | 12/4/2021 |
| Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis. | Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis.
Deng C, Peng N, Tang Y, Yu N, Wang C, Cai X, Zhang L, Hu D, Ciccia F, Lu L., Free PMC Article | 10/30/2021 |
| CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma. | CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.
Lin J, Qin H, Han Y, Li X, Zhao Y, Zhai G., Free PMC Article | 10/2/2021 |
| The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis. | The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis.
García-Arellano S, Hernández-Palma LA, Cerpa-Cruz S, Sánchez-Zuno GA, Herrera-Godina MG, Muñoz-Valle JF., Free PMC Article | 09/11/2021 |
| Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis. | Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
Fukayama M, Yoshizaki A, Fukasawa T, Ebata S, Kuzumi A, Yoshizaki-Ogawa A, Asano Y, Oba K, Sato S. | 07/3/2021 |
| Interleukin-25 regulates matrix metalloproteinase-2 and -9 expression in periodontal fibroblast cells through ERK and P38MAPK pathways. | Interleukin-25 regulates matrix metalloproteinase-2 and -9 expression in periodontal fibroblast cells through ERK and P38MAPK pathways.
Pan S, Zhang Z, Li C, Yang D. | 06/26/2021 |
| Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects. | Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects.
Barati M, Sinaeian M, Shokrollahi Barough M, Pak F, Semnani V, Kokhaei P, Momtazi-Borojeni AA. | 06/19/2021 |
| Long non-coding RNA FOXD3-AS1 regulates the expression and secretion of IL-25 in nasal epithelial cells to inhibit Th2 type immunoreaction in allergic rhinitis. | Long non-coding RNA FOXD3-AS1 regulates the expression and secretion of IL-25 in nasal epithelial cells to inhibit Th2 type immunoreaction in allergic rhinitis.
Zhang H, Zhu X, Liu X, Wang Y, Liu Y. | 05/1/2021 |
| Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis. | Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis.
Jaworek AK, Szafraniec K, Zuber Z, Wojas-Pelc A, Jaworek J. | 04/24/2021 |
| Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome. | Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjögren's syndrome.
Zhao X, Gan Y, Jin Y, He J, Jia R, Li Y, Luan H, Ye H, Wang Q, Liu Y, Shen D, Sun X, Li Z. | 04/24/2021 |
| [Down-regulation of IL-25 accompanied by a decrease in the number of M2 macrophages in patients of non-alcoholic fatty liver disease with significant liver fibrosis]. | [Down-regulation of IL-25 accompanied by a decrease in the number of M2 macrophages in patients of non-alcoholic fatty liver disease with significant liver fibrosis].
Wu J, Xiao H, Zheng X, Zhang Z, Zhang Y, Zhu X, Wang A. | 04/3/2021 |